These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35120435)

  • 1. Studying patterns and predictors of HIV viral suppression using A Big Data approach: a research protocol.
    Zhang J; Olatosi B; Yang X; Weissman S; Li Z; Hu J; Li X
    BMC Infect Dis; 2022 Feb; 22(1):122. PubMed ID: 35120435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using big data analytics to improve HIV medical care utilisation in South Carolina: A study protocol.
    Olatosi B; Zhang J; Weissman S; Hu J; Haider MR; Li X
    BMJ Open; 2019 Jul; 9(7):e027688. PubMed ID: 31326931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual orientation and gender identity measures and viral suppression for people living with HIV: a protocol for a population-based cohort study.
    Yang X; Olatosi B; Weissman S; Li X; Zhang J
    BMJ Open; 2024 Feb; 14(2):e076997. PubMed ID: 38326246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of racial/ethnic disparities in HIV care continuum in the Southern USA: protocol for a population-based cohort study.
    Yang X; Zhang J; Olatosi B; Li Z; Weissman S; Li X
    BMJ Open; 2023 Dec; 13(12):e080521. PubMed ID: 38086599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair levels of steroid, endocannabinoid, and the ratio biomarkers predict viral suppression among people living with HIV/AIDS in China.
    Chu L; Liu S; Wu Y; Yang J; Qiao S; Zhou Y; Deng H; Li X; Shen Z
    Clin Chim Acta; 2022 Oct; 535():143-152. PubMed ID: 36041548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for developing a personalised prediction model for viral suppression among under-represented populations in the context of the COVID-19 pandemic.
    Zhang J; Yang X; Weissman S; Li X; Olatosi B
    BMJ Open; 2023 May; 13(5):e070869. PubMed ID: 37188476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
    Sutton SS; Magagnoli J; Hardin JW
    Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderation effect of community health on the relationship between racial/ethnic residential segregation and HIV viral suppression in South Carolina: A county-level longitudinal study from 2013 to 2018.
    Shi F; Zhang J; Yang X; Sun X; Li Z; Zeng C; Ning H; Weissman S; Olatosi B; Li X
    Front Public Health; 2022; 10():1013967. PubMed ID: 36699939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of a distributed data network between an academic institution and state health departments to investigate variation in time to HIV viral suppression in the Deep South.
    Bassler JR; Cagle I; Crear D; Kay ES; Long DM; Mugavero MJ; Nassel AF; Ostrenga L; Parman M; Preg S; Wang X; Batey DS; Rana A; Levitan EB
    BMC Public Health; 2023 May; 23(1):937. PubMed ID: 37226199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing Big Data analytics and electronic health record data in HIV prevention, treatment, and care research: a literature review.
    Qiao S; Li X; Olatosi B; Young SD
    AIDS Care; 2024 May; 36(5):583-603. PubMed ID: 34260325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Nance RM; Delaney JAC; Simoni JM; Wilson IB; Mayer KH; Whitney BM; Aunon FM; Safren SA; Mugavero MJ; Mathews WC; Christopoulos KA; Eron JJ; Napravnik S; Moore RD; Rodriguez B; Lau B; Fredericksen RJ; Saag MS; Kitahata MM; Crane HM
    Ann Intern Med; 2018 Sep; 169(6):376-384. PubMed ID: 30140916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impacts of HIV-Related Service Interruptions During the COVID-19 Pandemic: Protocol of a Mixed Methodology Longitudinal Study.
    Qiao S; Zhang J; Li Z; Olatosi B; Weissman S; Li X
    AIDS Behav; 2023 Aug; ():. PubMed ID: 37526786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.
    Yang X; Zhang J; Chen S; Weissman S; Olatosi B; Li X
    AIDS; 2021 May; 35(Suppl 1):S39-S51. PubMed ID: 33867488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa.
    Shoko C; Chikobvu D
    Theor Biol Med Model; 2018 Jul; 15(1):10. PubMed ID: 30008270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Failure to Reach Viral Suppression Within 1 Year After Human Immunodeficiency Virus Diagnosis: A Surveillance-Based Analysis.
    Whelan BM; Hebert PL; Ahrens KR; Katz DA; Buskin SE; Golden MR; Dombrowski JC
    Sex Transm Dis; 2019 Nov; 46(11):728-732. PubMed ID: 31644501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study.
    Fuge TG; Tsourtos G; Miller ER
    AIDS Res Ther; 2022 Jan; 19(1):5. PubMed ID: 35093100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.